Cas:306936-31-2 ethyl 5-(4-chlorophenyl)-4-chlorosulfonyl-2-methyl-1-phenylpyrrole-3-carboxylate manufacturer & supplier

Chemical Name:ethyl 5-(4-chlorophenyl)-4-chlorosulfonyl-2-methyl-1-phenylpyrrole-3-carboxylate

CAS.NO:306936-31-2

Synonyms:ethyl 5-(4-chlorophenyl)-4-chlorosulfonyl-2-methyl-1-phenylpyrrole-3-carboxylate

Molecular Formula:C₂₀H₁₇Cl₂NO₄S

Molecular Weight:438.32400

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:73.75000

Exact Mass:437.02600

LogP:6.29110

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like ethyl 5-(4-chlorophenyl)-4-chlorosulfonyl-2-methyl-1-phenylpyrrole-3-carboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,ethyl 5-(4-chlorophenyl)-4-chlorosulfonyl-2-methyl-1-phenylpyrrole-3-carboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,ethyl 5-(4-chlorophenyl)-4-chlorosulfonyl-2-methyl-1-phenylpyrrole-3-carboxylate Use and application,ethyl 5-(4-chlorophenyl)-4-chlorosulfonyl-2-methyl-1-phenylpyrrole-3-carboxylate technical grade,usp/ep/jp grade.

Related News: In the current trial, a total of 196 patients were randomly chosen to receive either the vaccine or a placebo. ethyl 5-(4-chlorophenyl)-4-chlorosulfonyl-2-methyl-1-phenylpyrrole-3-carboxylate manufacturer In 2016, in order to promote the innovative development, transformation and upgrading of the pharmaceutical industry, the Development and Reform Commission led the compilation of the Guiding Opinions on Promoting the Healthy Development of the Pharmaceutical Industry, which put forward requirements for all aspects of the medical industry and specifically proposed support for the field of chemical raw materials. . ethyl 5-(4-chlorophenyl)-4-chlorosulfonyl-2-methyl-1-phenylpyrrole-3-carboxylate supplier In 2016, in order to promote the innovative development, transformation and upgrading of the pharmaceutical industry, the Development and Reform Commission led the compilation of the Guiding Opinions on Promoting the Healthy Development of the Pharmaceutical Industry, which put forward requirements for all aspects of the medical industry and specifically proposed support for the field of chemical raw materials. . ethyl 5-(4-chlorophenyl)-4-chlorosulfonyl-2-methyl-1-phenylpyrrole-3-carboxylate vendor China is fast-tracking approval for innovative drugs at home in a bid to offer more and cheaper options to patients, as many in the rapidly aging country struggle to find alternatives to costly treatments sold by multinational pharmaceutical firms for chronic diseases. ethyl 5-(4-chlorophenyl)-4-chlorosulfonyl-2-methyl-1-phenylpyrrole-3-carboxylate factory The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it.